Marc Beer is an entrepreneur with a proven track record. For over 25 years, he has helped to transform companies into highly successful business ventures by creating sustainable and specific solutions to each one’s unique challenges. As a graduate of business from Miami University, Beer has combined his natural instincts and skills with an education that enhanced his abilities and allowed for great opportunities for his success. As Vice President of Global Marketing at Genzyme, Marc Beer created a marketing campaign that brought notoriety and awareness to the company that hadn’t previously existed. Furthermore, the product line that Genzyme offered was to aid individuals who were suffering from rare diseases,; a cause that became quite personal to Beer. This position launched Marc Beer’s career to developing solutions to the unique challenges that pharmaceutical companies face in getting their products to those who need it most.
Viacell was Marc Beer’s first entrepreneurial business venture. Launched in 2000, the company cornered the market by investing in the preservation and collection of umbilical cord stem cells. These cells could be developed to be used as a treatment for several conditions within human beings. Viacell went public on the New York Stock Exchange in 2005 and was eventually sold to the life science conglomerate PerkinElmer in 2007 for $300 million. Viacell’s success has cemented Marc Beer’s role in the future of pharmaceuticals that will treat several conditions that humans were suffering from and enhance their overall lives.
The most recent story of success for Marc Beer originates in an unfortunate tragedy. A short time after the sale of Viacell, Beer’s wife died suddenly. This overwhelming circumstance plunged Beer into a life whose sole intention was enveloped within the well being of his children. It was one of his children that encouraged him to continue his work as a man who made a difference in the world. From this encouragement, Marc Beer embarked on his next entrepreneurial adventure, Renovia.
To create the company Renovia, Marc Beer partnered with a gynecologist Dr. Ray Iglesias to create alternatives to surgery for women with pelvic afflictions. The two, along with Yolanda Lorié, founded the firm in 2016 as a company that focuses on the diagnosis and treatment of women’s pelvic floor disorders. By focusing on medical technological advancements and development, Renovia aimed to offer women suffering from this affliction an alternative to surgical intrusion and in 2018 achieved his first successful FDA approval of the drug Leva.
Marc Beer has cultivated his love for his fellow man into a long-standing and prosperous career in the pharmaceutical niche. His belief in surrounding himself with the right talent as well as setting and achieving specific goals within his business gives him the motivation necessary to continue his success and bring further enhancements to the lives of others that are suffering. Marc BeerBeer hopes that each success is merely another step towards removing stigmas of pains and discomforts thus leading to further innovation and treatments for the future. Learn more: https://www.crunchbase.com/person/marc-beer